Regulation of TLR4 signaling and the host interface with pathogens and danger: The role of RP105

Journal of Leukocyte Biology

Volumn 82, Issue 2, 2007, Pages 265-271

  Divanovic, Senad ^a   Trompette, Aurelien ^a   Petiniot, Lisa K ^a   Allen, Jessica L ^a   Flick, Leah M ^a   Belkaid, Yasmine ^b   Madan, Rajat ^a   Haky, Jennifer J ^a   Karp, Christopher L ^a,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

Counter regulation; Endogenous ligand; MD 1

Indexed keywords

ANTIGEN; CD40 ANTIGEN; NOD LIKE RECEPTOR; RIG 1 LIKE RECEPTOR; RP105 ANTIGEN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOBIOLOGY; INNATE IMMUNITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD; GENE EXPRESSION REGULATION; HUMANS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 34547814263     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0107021     Document Type: Review

References (82)

1. Backhed, F., Hornef, M. (2003) Toll-like receptor 4-mediated signaling by epithelial surfaces: necessity or threat? Microbes Infect. 5, 951-959.
2. Wysocka, M., Robertson, S., Riemann, H., Caamano, J., Hunter, C., Mackiewicz, A., Montaner, L. J., Trinchieri, G., Karp, C. L. (2001) Il-12 suppression during experimental endotoxin tolerance: dendritic cell loss and macrophage hyporesponsiveness. J. Immunol. 166, 7504-7513.
3. Cross, A. S. (2002) Endotoxin tolerance-current concepts in historical perspective. J. Endotoxin Res. 8, 83-98.
4. Lu, M., Zhang, M., Takashima, A., Weiss, J., Apicella, M. A., Li, X. H., Yuan, D., Munford, R. S. (2005) Lipopolysaccharide deacylation by an endogenous lipase controls innate antibody responses to Gram-negative bacteria. Nat. Immunol. 6, 989-994.
5. Brunn, G. J., Bungum, M. K., Johnson, G. B., Platt, J. L. (2005) Conditional signaling by Toll-like receptor 4. FASEB J. 19, 872-874.
6. Samarasinghe, R., Tailor, P., Tamura, T., Kaisho, T., Akira, S., Ozato, K. (2006) Induction of an anti-inflammatory cytokine, IL-10, in dendritic cells after Toll-like receptor signaling. J. Interferon Cytokine Res. 26, 893-900.
7. Aliberti, J., Hieny, S., Reis e Sousa, C., Serhan, C. N., Sher, A. (2002) Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nat. Immunol. 3, 76-82.
8. Sutmuller, R. P., den Brok, M. H., Kramer, M., Bennink, E. J., Toonen, L. W., Kullberg, B. J., Joosten, L. A., Akira, S., Netea, M. G., Adema, G. J. (2006) Toll-like receptor 2 controls expansion and function of regulatory T cells. J. Clin. Invest. 116, 485-494.
9. Hawlisch, H., Belkaid, Y., Baelder, R., Hildeman, D., Gerard, C., Kohl, J. (2005) C5a negatively regulates Toll-like receptor 4-induced immune responses. Immunity 22, 415-426.
10. Grazia Cappiello, M., Sutterwala, F. S., Trinchieri, G., Mosser, D. M., Ma, X. (2001) Suppression of IL-12 transcription in macrophages following Fc - receptor ligation. J. Immunol. 166, 4498-4506.
11. Aliprantis, A. O., Yang, R. B., Mark, M. R., Suggett, S., Devaux, B., Radolf, J. D., Klimpel, G. R., Godowski, P., Zychlinsky, A. (1999) Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 285, 736-739.
12. Liew, F. Y., Xu, D., Brint, E. K., O'Neill, L. A. (2005) Negative regulation of Toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5, 446-458.
13. Divanovic, S., Trompette, A., Atabani, S. F., Madan, R., Golenbock, D. T., Visintin, A., Finberg, R. W., Tarakhovsky, A., Vogel, S. N., Belkaid, Y., Kurt-Jones, E. A., Karp, C. L. (2005) Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat. Immunol. 6, 571-578.
14. Iwami, K. I., Matsuguchi, T., Masuda, A., Kikuchi, T., Musikacharoen, T., Yoshikai, Y. (2000) Cutting edge: naturally occurring soluble form of mouse Toll-like receptor 4 inhibits lipopolysaccharide signaling. J. Immunol. 165, 6682-6686.
15. Mitsuzawa, H., Nishitani, C., Hyakushima, N., Shimizu, T., Sano, H., Matsushima, N., Fukase, K., Kuroki, Y. (2006) Recombinant soluble forms of extracellular TLR4 domain and MD-2 inhibit lipopolysaccharide binding on cell surface and dampen lipopolysaccharide-induced pulmonary inflammation in mice. J. Immunol. 177, 8133-8139.
16. LeBouder, E., Rey-Nores, J. E., Rushmere, N. K., Grigorov, M., Lawn, S. D., Affolter, M., Griffin, G. E., Ferrara, P., Schiffrin, E. J., Morgan, B. P., Labeta, M. O. (2003) Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J. Immunol. 171, 6680-6689.
17. Sweet, M. J., Leung, B. P., Kang, D., Sogaard, M., Schulz, K., Trajkovic, V., Campbell, C. C., Xu, D., Liew, F. Y. (2001) A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J. Immunol. 166, 6633-6639.
18. Wald, D., Qin, J., Zhao, Z., Qian, Y., Naramura, M., Tian, L., Towne, J., Sims, J. E., Stark, G. R., Li, X. (2003) SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 4, 920-927.
19. Qin, J., Qian, Y., Yao, J., Grace, C., Li, X. (2005) SIGIRR inhibits interleukin-1 receptor- and Toll-like receptor 4-mediated signaling through different mechanisms. J. Biol. Chem. 280, 25233-25241.
20. Diehl, G. E., Yue, H. H., Hsieh, K., Kuang, A. A., Ho, M., Morici, L. A., Lenz, L. L., Cado, D., Riley, L. W., Winoto, A. (2004) TRAIL-R as a negative regulator of innate immune cell responses. Immunity 21, 877-889.
21. Boone, D. L., Turer, E. E., Lee, E. G., Ahmad, R. C., Wheeler, M. T., Tsui, C., Hurley, P., Chien, M., Chai, S., Hitotsumatsu, O., McNally, E., Pickart, C., Ma, A. (2004) The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat. Immunol. 5, 1052-1060.
22. Wullaert, A., Verstrepen, L., Van Huffel, S., Adib-Conquy, M., Cornelis, S., Kreike, M., Haegman, M., El Bakkouri, K., Sanders, M., Verhelst, K., Carpentier, I., Cavaillon, J. M., Heyninck, K., Beyaert, R. (2007) LIND/ABIN-3 is a novel lipopolysaccharide-inducible inhibitor of NF-κB activation. J. Biol. Chem. 282, 81-90.
23. Gilchrist, M., Thorsson, V., Li, B., Rust, A. G., Korb, M., Kennedy, K., Hai, T., Bolouri, H., Aderem, A. (2006) Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 441, 173-178.
24. Wang, Y., Tang, Y., Teng, L., Wu, Y., Zhao, X., Pei, G. (2006) Association of β-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 7, 139-147.
25. Shinohara, H., Inoue, A., Toyama-Sorimachi, N., Nagai, Y., Yasuda, T., Suzuki, H., Horai, R., Iwakura, Y., Yamamoto, T., Karasuyama, H., Miyake, K., Yamanashi, Y. (2005) Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling. J. Exp. Med. 201, 333-339.
26. Kobayashi, K., Hernandez, L. D., Galan, J. E., Janeway Jr., C. A., Medzhitov, R., Flavell, R. A. (2002) IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110, 191-202.
27. Hardy, M. P., O'Neill, L. A. (2004) The murine IRAK2 gene encodes four alternatively spliced isoforms, two of which are inhibitory. J. Biol. Chem. 279, 27699-27708.
28. Williams, K. L., Lich, J. D., Duncan, J. A., Reed, W., Rallabhandi, P., Moore, C., Kurtz, S., Coffield, V. M., Accavitti-Loper, M. A., Su, L., Vogel, S. N., Braunstein, M., Ting, J. P. (2005) The CATERPILLER protein Monarch-1 is an antagonist of Toll-like receptor-, tumor necrosis factor α-, and Mycobacterium tuberculosis-induced pro-inflammatory signals. J. Biol. Chem. 280, 39914-39924.
29. Janssens, S., Burns, K., Vercammen, E., Tschopp, J., Beyaert, R. (2003) MyD88S, a splice variant of MyD88, differentially modulates NF-κB- and AP-1-dependent gene expression. FEBS Lett. 548, 103-107.
30. Burns, K., Janssens, S., Brissoni, B., Olivos, N., Beyaert, R., Tschopp, J. (2003) Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J. Exp. Med. 197, 263-268.
31. Carty, M., Goodbody, R., Schroder, M., Stack, J., Moynagh, P. N., Bowie, A. G. (2006) The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat. Immunol. 7, 1074-1081.
32. Mansell, A., Smith, R., Doyle, S. L., Gray, P., Fenner, J. E., Crack, P. J., Nicholson, S. E., Hilton, D. J., O'Neill, L. A., Hertzog, P. J. (2006) Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat. Immunol. 7, 148-155.
33. Chuang, T. H., Ulevitch, R. J. (2004) Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors. Nat. Immunol. 5, 495-502.
34. Vogel, S. N., Fitzgerald, K. A., Fenton, M. J. (2003) TLRs: differential adapter utilization by Toll-like receptors mediates TLR-specific patterns of gene expression. Mol. Interv. 3, 466-477.
35. Seong, S. Y., Matzinger, P. (2004) Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 4, 469-478.
36. Okamura, Y., Watari, M., Jerud, E. S., Young, D. W., Ishizaka, S. T., Rose, J., Chow, J. C., Strauss III, J. F. (2001) The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem. 276, 10229-10233.
37. Termeer, C., Benedix, F., Sleeman, J., Fieber, C., Voith, U., Ahrens, T., Miyake, K., Freudenberg, M., Galanos, C., Simon, J. C. (2002) Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4. J. Exp. Med. 195, 99-111.
38. Biragyn, A., Ruffini, P. A., Leifer, C. A., Klyushnenkova, E., Shakhov, A., Chertov, O., Shirakawa, A. K., Farber, J. M., Segal, D. M., Oppenheim, J. J., Kwak, L. W. (2002) Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2. Science 298, 1025-1029.
39. Miller, Y. I., Viriyakosol, S., Worrall, D. S., Boullier, A., Butler, S., Witztum, J. L. (2005) Toll-like receptor 4-dependent and independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler. Thromb. Vasc. Biol. 25, 1213-1219.
40. Smiley, S. T., King, J. A., Hancock, W. W. (2001) Fibrinogen stimulates macrophage chemokine secretion through Toll-like receptor 4. J. Immunol. 167, 2887-2894.
41. Yu, M., Wang, H., Ding, A., Golenbock, D. T., Latz, E., Czura, C. J., Fenton, M. J., Tracey, K. J., Yang, H. (2006) HMGB1 signals through Toll-like receptor (TLR) 4 and TLR2. Shock 26, 174-179.
42. Scheibner, K. A., Lutz, M. A., Boodoo, S., Fenton, M. J., Powell, J. D., Horton, M. R. (2006) Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J. Immunol. 177, 1272-1281.
43. Tsan, M. F., Gao, B. (2004) Endogenous ligands of Toll-like receptors. J. Leukoc. Biol. 76, 514-519.
44. Beutler, B. (2004) Inferences, questions and possibilities in Toll-like receptor signaling. Nature 430, 257-263.
45. Oyama, J., Blais Jr., C., Liu, X., Pu, M., Kobzik, L., Kelly, R. A., Bourcier, T. (2004) Reduced myocardial ischemia-reperfusion injury in Toll-like receptor 4-deficient mice. Circulation 109, 784-789.
46. Kleeberger, S. R., Reddy, S., Zhang, L. Y., Jedlicka, A. E. (2000) Genetic susceptibility to ozone-induced lung hyperpermeability: role of Toll-like receptor 4. Am. J. Respir. Cell Mol. Biol. 22, 620-627.
47. Kleeberger, S. R., Reddy, S. P., Zhang, L. Y., Cho, H. Y., Jedlicka, A. E. (2001) Toll-like receptor 4 mediates ozone-induced murine lung hyperpermeability via inducible nitric oxide synthase. Am. J. Physiol. Lung Cell. Mol. Physiol. 280, L326-L333.
48. Tanga, F. Y., Nutile-McMenemy, N., Deleo, J. A. (2005) The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc. Natl. Acad. Sci. USA 102, 5856-5861.
49. Miyake, K., Yamashita, Y., Hitoshi, Y., Takatsu, K., Kimoto, M. (1994) Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells. J. Exp. Med. 180, 1217-1224.
50. Miyake, K., Yamashita, Y., Ogata, M., Sudo, T., Kimoto, M. (1995) RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family. J. Immunol. 154, 3333-3340.
51. Miura, Y., Miyake, K., Yamashita, Y., Shimazu, R., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Inazawa, J., Abe, T., Kimoto, M. (1996) Molecular cloning of a human RP105 homologue and chromosomal localization of the mouse and human RP105 genes (Ly64 and LY64). Genomics 38, 299-304.
52. Fugier-Vivier, I., de Bouteiller, O., Guret, C., Fossiez, F., Banchereau, J., Mattei, M. G., Ait-Yahia, S., Garcia, E., Lebecque, S., Liu, Y. J. (1997) Molecular cloning of human RP105. Eur. J. Immunol. 27, 1824-1827.
53. Roshak, A. K., Anderson, K. M., Holmes, S. D., Jonak, Z., Bolognese, B., Terrett, J., Marshall, L. A. (1999) Anti-human RP105 sera induces lymphocyte proliferation. J. Leukoc. Biol. 65, 43-49.
54. Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K., Kimoto, M. (1999) MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll- like receptor 4. J. Exp. Med. 189, 1777-1782.
55. Schromm, A. B., Lien, E., Henneke, P., Chow, J. C., Yoshimura, A., Heine, H., Latz, E., Monks, B. G., Schwartz, D. A., Miyake, K., Golenbock, D. T. (2001) Molecular genetic analysis of an endotoxin nonresponder mutant cell line: a point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling. J. Exp. Med. 194, 79-88.
56. Re, F., Strominger, J. L. (2003) Separate functional domains of human MD-2 mediate Toll-like receptor 4-binding and lipopolysaccharide responsiveness. J. Immunol. 171, 5272-5276.
57. Re, F., Strominger, J. L. (2002) Monomeric recombinant MD-2 binds Toll-like receptor 4 tightly and confers lipopolysaccharide responsiveness. J. Biol. Chem. 277, 23427-23432.
58. Miyake, K., Shimazu, R., Kondo, J., Niki, T., Akashi, S., Ogata, H., Yamashita, Y., Miura, Y., Kimoto, M. (1998) Mouse MD-1, a molecule that is physically associated with RP105 and positively regulates its expression. J. Immunol. 161, 1348-1353.
59. Miura, Y., Shimazu, R., Miyake, K., Akashi, S., Ogata, H., Yamashita, Y., Narisawa, Y., Kimoto, M. (1998) RP105 is associated with MD-1 and transmits an activation signal in human B cells. Blood 92, 2815-2822.
60. Nagai, Y., Shimazu, R., Ogata, H., Akashi, S., Sudo, K., Yamasaki, H., Hayashi, S., Iwakura, Y., Kimoto, M., Miyake, K. (2002) Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide. Blood 99, 1699-1705.
61. Yamashita, Y., Miyake, K., Miura, Y., Kaneko, Y., Yagita, H., Suda, T., Nagata, S., Nomura, J., Sakaguchi, N., Kimoto, M. (1996) Activation mediated by RP105 but not CD40 makes normal B cells susceptible to anti-IgM-induced apoptosis: a role for Fc receptor coligation. J. Exp. Med. 184, 113-120.
62. Yazawa, N., Fujimoto, M., Sato, S., Miyake, K., Asano, N., Nagai, Y., Takeuchi, O., Takeda, K., Okochi, H., Akira, S., Tedder, T. F., Tamaki, K. (2003) CD19 regulates innate immunity by the Toll-like receptor RP105 signaling in B lymphocytes. Blood 102, 1374-1380.
63. Ogata, H., Su, I., Miyake, K., Nagai, Y., Akashi, S., Mecklenbrauker, I., Rajewsky, K., Kimoto, M., Tarakhovsky, A. (2000) The Toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells. J. Exp. Med. 192, 23-29.
64. Chan, V. W., Mecklenbrauker, I., Su, I., Texido, G., Leitges, M., Carsetti, R., Lowell, C. A., Rajewsky, K., Miyake, K., Tarakhovsky, A. (1998) The molecular mechanism of B cell activation by Toll-like receptor protein RP-105. J. Exp. Med. 188, 93-101.
65. Nagai, Y., Kobayashi, T., Motoi, Y., Ishiguro, K., Akashi, S., Saitoh, S., Kusumoto, Y., Kaisho, T., Akira, S., Matsumoto, M., Takatsu, K., Miyake, K. (2005) The radioprotective 105/MD-1 complex links TLR2 and TLR4/MD-2 in antibody response to microbial membranes. J. Immunol. 174, 7043-7049.
66. Visintin, A., Latz, E., Monks, B. G., Espevik, T., Golenbock, D. T. (2003) Lysines 128 and 132 enable lipopolysaccharide binding to MD-2, leading to Toll-like receptor-4 aggregation and signal transduction. J. Biol. Chem. 278, 48313-48320.
67. Tsuneyoshi, N., Fukudome, K., Kohara, J., Tomimasu, R., Gauchat, J. F., Nakatake, H., Kimoto, M. (2005) The functional and structural properties of MD-2 required for lipopolysaccharide binding are absent in MD-1. J. Immunol. 174, 340-344.
68. Nagai, Y., Akashi, S., Nagafuku, M., Ogata, M., Iwakura, Y., Akira, S., Kitamura, T., Kosugi, A., Kimoto, M., Miyake, K. (2002) Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 3, 667-672.
69. Visintin, A., Halmen, K. A., Khan, N., Monks, B. G., Golenbock, D. T., Lien, E. (2006) MD-2 expression is not required for cell surface targeting of Toll-like receptor 4 (TLR4). J. Leukoc. Biol. 80, 1584-1592.
70. Kropf, P., Freudenberg, M. A., Modolell, M., Price, H. P., Herath, S., Antoniazi, S., Galanos, C., Smith, D. F., Muller, I. (2004) Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major. Infect. Immun. 72, 1920-1928.
71. Kropf, P., Freudenberg, N., Kalis, C., Modolell, M., Herath, S., Galanos, C., Freudenberg, M., Muller, I. (2004) Infection of C57BL/10ScCr and C57BL/10ScNCr mice with Leishmania major reveals a role for Toll-like receptor 4 in the control of parasite replication. J. Leukoc. Biol. 76, 48-57.
72. Kikuchi, Y., Koarada, S., Tada, Y., Ushiyama, O., Morito, F., Suzuki, N., Ohta, A., Miyake, K., Kimoto, M., Horiuchi, T., Nagasawa, K. (2002) RP105-lacking B cells from lupus patients are responsible for the production of immunoglobulins and autoantibodies. Arthritis Rheum. 46, 3259-3265.
73. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., Medzhitov, R. (2004) Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241.
74. Fukata, M., Michelsen, K. S., Eri, R., Thomas, L. S., Hu, B., Lukasek, K., Nast, C. C., Lechago, J., Xu, R., Naiki, Y., Soliman, A., Arditi, M., Abreu, M. T. (2005) Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G1055-G1065.
75. Jiang, D., Liang, J., Fan, J., Yu, S., Chen, S., Luo, Y., Prestwich, G. D., Mascarenhas, M. M., Garg, H. G., Quinn, D. A., Homer, R. J., Goldstein, D. R., Bucala, R., Lee, P. J., Medzhitov, R., Noble, P. W. (2005) Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat. Med. 11, 1173-1179.
76. Taylor, K. R., Trowbridge, J. M., Rudisill, J. A., Termeer, C. C., Simon, J. C., Gallo, R. L. (2004) Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J. Biol. Chem. 279, 17079-17084.
77. Gorczynski, R. M., Kai, Y., Miyake, K. (2006) MD1 expression regulates development of regulatory T cells. J. Immunol. 177, 1078-1084.
78. Oliver, A. M., Martin, F., Kearney, J. F. (1999) IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J. Immunol. 162, 7198-7207.
79. Oliver, A. M., Martin, F., Gartland, G. L., Carter, R. H., Kearney, J. F. (1997) Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur. J. Immunol. 27, 2366-2374.
80. Gunn, K. E., Brewer, J. W. (2006) Evidence that marginal zone B cells possess an enhanced secretory apparatus and exhibit superior secretory activity. J. Immunol. 177, 3791-3798.
81. Akashi, S., Shimazu, R., Ogata, H., Nagai, Y., Takeda, K., Kimoto, M., Miyake, K. (2000) Cutting edge: cell surface expression and lipopolysaccharide signaling via the Toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J. Immunol. 164, 3471-3475.
82. Dziarski, R., Wang, Q., Miyake, K., Kirschning, C. J., Gupta, D. (2001) MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components. J. Immunol. 166, 1938-1944.